Human neonatal CITE-seq atlas identifies an immune transition at 32 weeks' gestation from CD15+ myeloid-dominated to interferon-primed immunity
Paula Rothämel, Alessandro Mattia, M I Corey, Barbara Puzek, Jana Wiesel, P Michael-Kuschel, Christoph Klein, Markus Sperandio, Philipp Henneke, Claudia Nußbaum, Sarah Kim-Hellmuth
The paper presents a CITE-seq atlas of human neonatal immune development, identifying a 32-week gestational transition to interferon-primed immunity.
bioRxiv · Apr 4, 2026 · PreprintImmunology